Share on StockTwits

PharMerica (NYSE:PMC) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, StockRatingsNetwork.com reports. One research analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $29.68.

PMC has been the subject of a number of recent research reports. Analysts at Cowen and Company upgraded shares of PharMerica from a “market perform” rating to an “outperform” rating in a research note on Wednesday. They now have a $33.00 price target on the stock, up previously from $31.00. Separately, analysts at Zacks upgraded shares of PharMerica from a “neutral” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $31.40 price target on the stock. Finally, analysts at Barclays initiated coverage on shares of PharMerica in a research note on Thursday, July 17th. They set an “underweight” rating on the stock.

PharMerica (NYSE:PMC) traded down 0.08% on Friday, hitting $25.48. The stock had a trading volume of 19,302 shares. PharMerica has a 52 week low of $12.15 and a 52 week high of $30.48. The stock’s 50-day moving average is $26.33 and its 200-day moving average is $27.04. The company’s market cap is $765.9 million.

PharMerica (NYSE:PMC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.40 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.36 by $0.04. The company had revenue of $448.60 million for the quarter, compared to the consensus estimate of $432.70 million. During the same quarter last year, the company posted $0.44 earnings per share. PharMerica’s revenue was up 4.1% compared to the same quarter last year. On average, analysts predict that PharMerica will post $1.52 earnings per share for the current fiscal year.

PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.